{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 15,
        "end": 30
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 15,
        "end": 19
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 124,
        "end": 127
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 135,
        "end": 138
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 182,
        "end": 187
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 190,
        "end": 194
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 0,
        "end": 51
      }
    },
    {
      "id": "T11",
      "obj": "Chemical",
      "span": {
        "begin": 34,
        "end": 37
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25145853_6",
  "text": "Conjugation of TLR9 ligand CpG to LDH nanoparticles significantly enhanced the antibody response and promoted a switch from Th2 toward Th1 response , demonstrated by a change in the IgG2a : IgG1 ratio ."
}
